Apeiron Capital LTD Moderna, Inc. Transaction History

Apeiron Capital LTD

$115 Million
Q2 2024

A detailed history of Apeiron Capital LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Apeiron Capital LTD holds 27,115 shares of MRNA stock, worth $1.78 Million. This represents 2.79% of its overall portfolio holdings.

Number of Shares

27,115

Previous 7,069 283.58%

Holding current value

$1.78 Million

Previous $753,000 327.49%

% of portfolio

2.79%

Previous 0.41%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$101.21 - $166.61 $2.03 Million - $3.34 Million	20,046 Added 283.58%	27,115 $3.22 Million
Q1 2024 Apr 11, 2024	SELL	$85.37 - $115.44 $2.06 Million - $2.79 Million	-24,131 Reduced 77.34%	7,069 $753,000
Q4 2023 Jan 31, 2024	BUY	$69.51 - $104.43 $1.06 Million - $1.6 Million	15,300 Added 96.23%	31,200 $3.1 Million
Q2 2023 Jul 24, 2023	SELL	$118.5 - $160.53 $841,350 - $1.14 Million	-7,100 Reduced 30.87%	15,900 $1.93 Million
Q1 2023 Apr 24, 2023	BUY	$135.66 - $197.02 $3.12 Million - $4.53 Million	23,000 New	23,000 $3.53 Million
Q4 2021 Jan 26, 2022	BUY	$225.82 - $368.51 $700,042 - $1.14 Million	3,100 Added 3.53%	91,000 $23.1 Million
Q3 2021 Oct 29, 2021	BUY	$221.9 - $484.47 $1.31 Million - $2.86 Million	5,900 Added 7.2%	87,900 $33.8 Million
Q2 2021 Jul 14, 2021	BUY	$129.91 - $234.98 $6.11 Million - $11 Million	47,000 Added 134.29%	82,000 $19.3 Million
Q1 2021 Apr 12, 2021	BUY	$109.18 - $185.98 $3.82 Million - $6.51 Million	35,000 New	35,000 $4.58 Million

Others Institutions Holding MRNA

# of Institutions

1,112

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apeiron Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Apeiron Capital LTD with notifications on news.

Account

Apeiron Capital LTD Moderna, Inc. Transaction History